If your Brickell business has an FDA question that cannot wait — a medical device regulatory matter, an inspection, a deadline — start with what the rules actually require. Brickell is the financial capital of Latin American trade — the banks that finance Miami’s imports, the regional headquarters that direct them, and the executives who make product and market-entry decisions for the hemisphere all sit within a few blocks. Garg Law’s Miami office is here, at 1221 Brickell Avenue, in the middle of that corridor. The companies steering FDA-regulated product lines from Brickell towers need regulatory answers at deal speed — and the office handling them is on the same street.
The short answer
Device regulation runs from classification through clearance, registration, listing, quality systems and post-market reporting — and importers inherit their own slice of it as initial importers. The strategy work is choosing the right pathway; the survival work is keeping registrations, listings and quality records aligned when FDA looks.
What a medical device regulatory matter really involves
Every device question starts with classification: Class I, II or III determines whether the product needs a 510(k) clearance, a De Novo, a PMA — or only general controls. Getting there is a claims-and-technology analysis against FDA’s classification regulations, and it decides your cost, timeline and evidence burden before anything else does.
Operational compliance follows: annual establishment registration (with user fees) and device listing for manufacturers, specification developers and initial importers; foreign establishments need a U.S. agent. The quality system regulation governs design and production controls; UDI labeling, medical device reporting (MDR) for adverse events, and corrections-and-removals reporting round out the post-market regime.
Miami is one of the country’s busiest medical device trade corridors — manufacturing and distribution across the region, exports throughout Latin America, and imports through MIA daily. Import screening tests registrations and listings on every entry; unlisted devices, missing premarket clearance and labeling gaps surface as holds and detentions at exactly the wrong time.
How Garg Law handles it
- Classification and pathway strategy: 510(k), De Novo, PMA or exempt — with predicate and claims analysis
- Registration and listing architecture across manufacturers, importers and specification developers
- Quality system and labeling compliance, including UDI and the design controls FDA inspects
- Import compliance: initial-importer obligations, entry affirmations, and detention response for flagged shipments
- Post-market management — MDR reporting, corrections and removals, recall strategy and inspection response
Why Brickell manufacturers call us
The work around Brickell — international banking and trade finance, multinational regional headquarters, consumer brand offices, legal and professional services, import/export holding companies — is FDA-regulated at nearly every turn, and matters here move on Miami’s financial district, home to the banks, trade finance desks and regional headquarters that fund and direct hemispheric trade. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.
What not to do
- Marketing claims that outrun the 510(k) — new intended uses need new clearance
- Assuming the foreign manufacturer’s registration covers the U.S. importer — initial importers register too
- Skipping listing updates when products, models or labeling change
- Treating quality-system documentation as paperwork until the Form 483 arrives
- Importing devices without verifying clearance status and listing before the goods ship
Frequently asked questions
Does my product even count as a medical device?
If it is intended to diagnose, treat, mitigate or prevent disease, or affects body structure or function without chemical action, it likely does — and intended use is read from your claims. Wellness gadgets become regulated devices through marketing language all the time; the analysis is worth doing before launch.
What is the difference between 510(k), De Novo and PMA?
A 510(k) shows substantial equivalence to an existing predicate device; De Novo creates a new classification for novel lower-risk devices; PMA is full premarket approval with clinical evidence for Class III. Pathway choice is the single biggest driver of time and cost to market.
What does an initial importer of devices have to do?
Register as an establishment, ensure the devices are listed and properly cleared or approved, and maintain complaint-handling and MDR obligations. Importers who assume the foreign manufacturer handles FDA discover otherwise at the border — or during an inspection.
Why was my device shipment held at MIA?
Typical bases: the entry could not verify registration and listing, the device appeared to lack required clearance, labeling issues, or the manufacturer has inspection history. Entry affirmations must match FDA’s records exactly — mismatches read as violations even when the paperwork exists.
When must a device problem be reported to FDA?
Under MDR, deaths, serious injuries and malfunctions that could cause them must be reported on statutory timelines — generally within 30 days, faster for some events. Corrections and removals in the field carry their own reporting rule. Late awareness is not a defense; complaint systems exist to catch these in time.